Purdue Pharma LP’s petition to the Supreme Court to block a false claims whistle-blower suit was denied June 1 (Purdue Pharma LP v. United States ex rel. May, U.S., 13-1162, review denied 6/1/15).
Purdue filed its petition March 25, seeking review of a U.S. Court of Appeals for the Fourth Circuit decision that revived False Claims Act allegations brought by a former Purdue sales representative, Steven May, and Angela Radcliffe, the wife of a relator in a previous whistle-blower suit.
May and Radcliffe alleged that Purdue misrepresented the potency of its pain medication OxyContin versus alternative medicines ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.